Argenx Se (ARGX) Other Operating Expenses (2016 - 2026)
Argenx Se (ARGX) posted Other Operating Expenses of $15.0 million for Q1 2026, down 58.84% on a QoQ basis from $36.4 million in Q4 2025, and down 11.76% year-over-year from $17.0 million in Q1 2025.
Argenx Se (ARGX) Other Operating Expenses (2016 - 2026) Analysis & Trends
Argenx Se's Other Operating Expenses history runs 11 years deep, the most recent figure standing at $15.0 million for Q1 2026.
- Quarterly Other Operating Expenses fell 11.76% year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94.4 million (up 36.98% YoY) and the FY2025 annual result came in at $96.7 million, up 46.22% from the prior year.
- Other Operating Expenses was $15.0 million for Q1 2026 at Argenx Se, down from $36.4 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $36.4 million in Q4 2025 and bottomed at $8.0 million in Q4 2022.
- A 5-year average of $14.8 million and a median of $11.5 million in 2024 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses sank 60.47% — and 2024, when it surged 120.41%.
- Argenx Se's Other Operating Expenses stood at $8.0 million in 2022, then jumped by 38.3% to $11.0 million in 2023, then jumped by 120.41% to $24.3 million in 2024, then jumped by 50.27% to $36.4 million in 2025, then plunged by 58.84% to $15.0 million in 2026.
- Business Quant data shows ARGX's Other Operating Expenses at $15.0 million in Q1 2026, $36.4 million in Q4 2025, and $24.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.00 Mn |
| Dec 31, 2025 | 36.44 Mn |
| Sep 30, 2025 | 24.38 Mn |
| Jun 30, 2025 | 18.59 Mn |
| Mar 31, 2025 | 17.00 Mn |
| Dec 31, 2024 | 24.25 Mn |
| Sep 30, 2024 | 15.88 Mn |
| Jun 30, 2024 | 11.79 Mn |
| Mar 31, 2024 | 11.51 Mn |
| Dec 31, 2023 | 11.00 Mn |
| Sep 30, 2023 | 10.05 Mn |
| Jun 30, 2023 | 10.49 Mn |
| Mar 31, 2023 | 10.74 Mn |
| Dec 31, 2022 | 7.96 Mn |
| Sep 30, 2022 | 8.51 Mn |
| Jun 30, 2022 | 9.99 Mn |
| Mar 31, 2022 | 8.07 Mn |
| Dec 31, 2021 | 7.66 Mn |
| Sep 30, 2021 | 6.25 Mn |
| Jun 30, 2021 | 7.82 Mn |